ISBN: 9781588292612 - chemoinformatics: concepts, methods, and tools for drug discovery: 275 (18 risultati)

Hardcover. Condizione: New. NEW! Hardcover Edition.

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Hardcover. Condizione: Good. Ex- library book with stamps/ stickers.

Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condizione: New. pp. xiii + 524 1st Edition.

Condizione: New. pp. xiii + 524 Illus.

Condizione: Used. pp. xiii + 524.

Condizione: New. In English.

Condizione: New. authors describe a computational infrastructure to enable pharmaceutical researchers to efficiently access basic chemoinformatics tools and help in decision-making; text describes efforts to interface chemoinformatics approaches with high-throughput screening; provides an extensive discussion of QSAR approaches. Editor(s): Bajorath, Jurgen. Series: Methods in Molecular Biology. Num Pages: 524 pages, biography. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 32. Weight in Grams: 1063. . 2004. Hardback. . . . .…

Hardcover. Condizione: Brand New. 1st edition. 524 pages. 9.00x6.00x1.25 inches. In Stock.

Condizione: New. authors describe a computational infrastructure to enable pharmaceutical researchers to efficiently access basic chemoinformatics tools and help in decision-making; text describes efforts to interface chemoinformatics approaches with high-throughput screening; provides an extensive discussion of QSAR approaches. Editor(s): Bajorath, Jurgen. Series: Methods in Molecular Biology. Num Pages: 524 pages, biography. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 32. Weight in Grams: 1063. . 2004. Hardback. . . . . Books ship from the US and Ireland.…

Condizione: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.…

Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In the literature, several terms are used synonymously to name the topic of this book: chem-, chemi-, or chemo-informatics. A widely recognized de- nition of this discipline is the one by Frank Brown from 1998 (1) who defined chemoinformatics as the combination of 'all the information resources that a scientist needs to optimize the properties of a ligand to become a drug. ' In Brown's definition, two aspects play a fundamentally important role: de- sion support by computational means and drug discovery, which distinguishes it from the term 'chemical informatics' that was introduced at least ten years earlier and described as the application of information technology to ch- istry (not with a specific focus on drug discovery). In addition, there is of course 'chemometrics,' which is generally understood as the application of statistical methods to chemical data and the derivation of relevant statistical models and descriptors (2). The pharmaceutical focus of many developments and efforts in this area-and the current popularity of gene-to-drug or si- lar paradigms-is further reflected by the recent introduction of such terms as 'discovery informatics' (3), which takes into account that gaining kno- edge from chemical data alone is not sufficient to be ultimately successful in drug discovery. Such insights are well in accord with other views that the boundaries between bio- and chemoinformatics are fluid and that these d- ciplines should be closely combined or merged to significantly impact b- technology or pharmaceutical research (4). 540 pp. Englisch.…

Gebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Includes supplementary material: sn.pub/extrasIn the literature, several terms are used synonymously to name the topic of this book: chem-, chemi-, or chemo-informatics. A widely recognized de- nition of this discipline is the one by Frank Brown .…

Buch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In the literature, several terms are used synonymously to name the topic of this book: chem-, chemi-, or chemo-informatics. A widely recognized de- nition of this discipline is the one by Frank Brown from 1998 (1) who defined chemoinformatics as the combination of ¿all the information resources that a scientist needs to optimize the properties of a ligand to become a drug. ¿ In Brown¿s definition, two aspects play a fundamentally important role: de- sion support by computational means and drug discovery, which distinguishes it from the term ¿chemical informatics¿ that was introduced at least ten years earlier and described as the application of information technology to ch- istry (not with a specific focus on drug discovery). In addition, there is of course ¿chemometrics,¿ which is generally understood as the application of statistical methods to chemical data and the derivation of relevant statistical models and descriptors (2). The pharmaceutical focus of many developments and efforts in this areäand the current popularity of gene-to-drug or si- lar paradigms¿is further reflected by the recent introduction of such terms as ¿discovery informatics¿ (3), which takes into account that gaining kno- edge from chemical data alone is not sufficient to be ultimately successful in drug discovery. Such insights are well in accord with other views that the boundaries between bio- and chemoinformatics are fluid and that these d- ciplines should be closely combined or merged to significantly impact b- technology or pharmaceutical research (4).Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 540 pp. Englisch.…

Buch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In the literature, several terms are used synonymously to name the topic of this book: chem-, chemi-, or chemo-informatics. A widely recognized de- nition of this discipline is the one by Frank Brown from 1998 (1) who defined chemoinformatics as the combination of 'all the information resources that a scientist needs to optimize the properties of a ligand to become a drug. ' In Brown's definition, two aspects play a fundamentally important role: de- sion support by computational means and drug discovery, which distinguishes it from the term 'chemical informatics' that was introduced at least ten years earlier and described as the application of information technology to ch- istry (not with a specific focus on drug discovery). In addition, there is of course 'chemometrics,' which is generally understood as the application of statistical methods to chemical data and the derivation of relevant statistical models and descriptors (2). The pharmaceutical focus of many developments and efforts in this area-and the current popularity of gene-to-drug or si- lar paradigms-is further reflected by the recent introduction of such terms as 'discovery informatics' (3), which takes into account that gaining kno- edge from chemical data alone is not sufficient to be ultimately successful in drug discovery. Such insights are well in accord with other views that the boundaries between bio- and chemoinformatics are fluid and that these d- ciplines should be closely combined or merged to significantly impact b- technology or pharmaceutical research (4). …